Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

masila

Rank: Vice President [?]

Points: 818 [?]

Votes: 16 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

24.6M USD Financing

posted on May 16, 2016 07:03PM

So, Mr Dart comes to the rescue again just as Zenith is starting to run on empty. To me this implies that the trial must be going well, otherwise he wouldn't be putting in more cash. Hopefully we'll be getting some more news soon.

masila

2 Recommendations